NEW YORK -- Pfizer Inc. (NYSE :PFE) announced today that the SUN 1087 trial of sunitinib in combination with erlotinib versus erlotinib demonstrated a statistically significant improvement in Progression-Free but not in Overall Survival in patients with previously treated advanced non-small cell O

read more>>

An experimental vaccine prevented hepatitis E in all patients who received it in a study, making it a crucial development in combating the “scourge” of the virus, the U.S. Centers for Disease Control and Prevention saidMore than 112,000 healthy people age 16 to 65 from Jiangsu province

read more>>

A new analysis has found that short-term and long-term costs of prostate cancer care vary considerably based on which treatment strategy a man initially receivesPublished early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study finds that treatments that may be les

read more>>

CHESHIRE, Conn. -- Alexion Pharmaceuticals, Inc. today announced that the US Food and Drug Administration (FDA) has approved Alexion's Rhode Island manufacturing facility (ARIMF) in Smithfield, Rhode Island as a second source of commercial supply for Soliris(R) (eculizumabEarlier this year, Alexio

read more>>

A group of MEPs has asked the European Commission to establish a database to collect information on drugs taken by football players during their careers and to assess the causes of football-related disease, such as the deadly Amyotrophic Lateral Sclerosis (ALSItalian MEP Salvatore Iacolino (Europe

read more>>

When Hannah Ostrea was five months old, she was diagnosed with Gaucher's disease, a genetic condition in which the body lacks the enzyme needed to break down a fatty waste product called glucocerebroside, leaving it to accumulate in the body's organsThe disease is painful, with the excess glucocer

read more>>

WATERTOWN, Mass. -- "This is what we have all been working towards and fighting for," says Daniel Paul Perez, co-founder, president and CEO of the FSH Society and a 48-year-old patient with facioscapulohumeral muscular dystrophy (FSHD), applauding the researchers whose study on yesterday's "At las

read more>>

PORTLAND, Ore. -- YoCream International, Inc. (Pink Sheets: YOCM), raised $8,000 for the Brian Grant Foundation at a fundraising event held at their Company Store in Portland OregonThe Company and Foundation announced that all sales revenue generated on July 31st at the YoCream Frozen Yogurt Com

read more>>

On a frigid weekend in the winter of 2004, a medical charity held a meeting at the Yarrow Hotel in Park City, Utah, to discuss a problemIt had been nearly ten years since geneticists Irwin McLean and Frances Smith had discovered the genetic underpinnings of pachyonychia congenita, a rare and extre

read more>>

THE WOODLANDS, Texas -- US Oncology, Inc., the nation's leading integrated oncology company, announced today that in less than two decades it has played a role in the development of 42 novel cancer therapies approved by the US Food and Drug Administration (FDATasigna® (nilotinib) capsules, a

read more>>